Organon & Co | SCHULD



Debt Veränderung Datum
Adcock Ingram Holdings ZAR 280.54M 199.53M 2024-06
Bristol-Myers Squibb USD 49.65B 103M 2024-12
Celltrion KRW 2.19T 18.16B 2024-09
Cspc Pharmaceutical CNY 388.87M 318.03M 2024-06
Dianthus Therapeutics USD 0 0 2024-09
Ecofibre AUD 25.49M 285K 2024-06
Gilead Sciences USD 26.71B 3.46B 2024-12
Glaxosmithkline GBP 16.99B 927M 2024-12
Kangmei Pharma CNY 253.72M 1.04B 2024-09
Knight Therapeutics CAD 58.22M 109K 2024-09
Laboratorios Farma EUR 121.16M 39.38M 2024-06
Malin Corporation EUR 0 100K 2024-06
Medical Developments International AUD 2.29M 140K 2024-06
Merck USD 37.11B 1.02B 2024-12
Neuren Pharmaceuticals AUD 0 0 2024-12
Novartis USD 31.26B 828M 2024-12
Organigram Holdings CAD 44.74M 12.56M 2024-12
Organon & Co USD 8.9B 151M 2024-12
Pharma Mar EUR 51.08M 1.99M 2024-12
Qiagen NV USD 1.39B 528.29M 2024-12
Sartorius EUR 4.53B 98.7M 2024-09
Sino Biopharmaceutical CNY 9.68B 2.9B 2024-06
Tilray USD 351.72M 15.26M 2024-11



Organon & Co SCHULD - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2025.